Detalhe da pesquisa
1.
Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels.
Gastroenterology
; 164(4): 669-679.e6, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642151
2.
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion.
Clin Gastroenterol Hepatol
; 22(3): 581-590.e6, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871842
3.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483300
4.
Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function.
Hepatology
; 77(2): 379-394, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073601
5.
Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.
J Med Virol
; 96(5): e29686, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767142
6.
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
J Med Virol
; 96(5): e29675, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746997
7.
Serum RNase L levels in patients with chronic hepatitis B virus infection.
Hepatol Res
; 54(3): 244-251, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861347
8.
Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease.
J Formos Med Assoc
; 123(1): 36-44, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491179
9.
Comparison of CT and gadoxetic acid-enhanced MRI with liver imaging reporting and data system to assess liver tumors before resection.
J Formos Med Assoc
; 123(3): 318-324, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38044205
10.
Environment contamination and intra-hospital spread of COVID-19 in a tertiary care Hospital in Taiwan.
J Formos Med Assoc
; 123(1): 45-54, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625983
11.
Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis.
J Formos Med Assoc
; 123(1): 88-97, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349170
12.
Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy.
J Formos Med Assoc
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423922
13.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208843
14.
Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 21(2): 424-434.e5, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131346
15.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(6): 1513-1522.e4, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863683
16.
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Gastroenterology
; 162(3): 757-771.e4, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762906
17.
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 118(9): 1601-1608, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719174
18.
Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months.
Hepatol Res
; 53(10): 1021-1030, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291079
19.
Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy.
J Formos Med Assoc
; 122(7): 564-573, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872131
20.
Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis.
J Formos Med Assoc
; 122(8): 747-756, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868900